Literature DB >> 14762792

Phosphatidylinositide 3-kinase gamma regulates key pathologic responses to cholecystokinin in pancreatic acinar cells.

Ilya Gukovsky1, Jason H Cheng, Kyung J Nam, Oliver T Lee, Aurelia Lugea, Lars Fischer, Josef M Penninger, Stephen J Pandol, Anna S Gukovskaya.   

Abstract

BACKGROUND & AIMS: Early events in the pancreatic acinar cell critical for development of pancreatitis include activation of the transcription factor nuclear factor kappa B (NF-kappa B), abnormal Ca(2+) responses, and trypsinogen activation. Mechanisms underlying these responses, which can be studied in isolated pancreatic acini stimulated with supraphysiologic doses of cholecystokinin (CCK-8), remain poorly understood. We here report that these responses are regulated by phosphatidylinositide 3-kinase (PI3K) gamma.
METHODS: To inactivate PI3K, we used mice deficient in the catalytic PI3K gamma subunit p110 gamma as well as the PI3K inhibitors LY294002 and wortmannin. We measured Ca(2+) responses by using Fura-2, NF-kappa B-binding activity by electromobility shift assay, I kappa B degradation by Western blotting, and trypsinogen activation by fluorogenic assay.
RESULTS: CCK-induced intracellular Ca(2+) mobilization, Ca(2+) influx, trypsinogen, and NF-kappa B activation were all diminished in pancreatic acini isolated from p110 gamma(-/-) mice. Both in mouse and rat acini, these responses were inhibited by the PI3K inhibitors. The Ca(2+) signal and trypsinogen activation were similarly reduced in acini isolated from p110 gamma(-/-) and p110 gamma(+/-) mice compared with wild-type mice. By contrast, NF-kappa B activation was inhibited in p110 gamma(-/-) acini but not in p110 gamma(+/-) acini. These differences indicate that the mechanism of NF-kappa B regulation by PI3K gamma differs from those for the Ca(2+) and trypsinogen responses. CCK-induced responses in p110 gamma(-/-) acini were all further inhibited by LY294002, indicating the involvement of other PI3K isoform(s), in addition to PI3K gamma.
CONCLUSIONS: The results show that key pathologic responses of the pancreatic acinar cell are regulated by PI3K gamma and suggest an important role for this PI3K isoform in pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762792     DOI: 10.1053/j.gastro.2003.11.017

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Driver mutations: a roadmap for getting close and personal in pancreatic cancer.

Authors:  Murray Korc
Journal:  Cancer Biol Ther       Date:  2010-09-24       Impact factor: 4.742

2.  The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.

Authors:  Bernardo Nuche-Berenguer; Irene Ramos-Álvarez; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2016-02-18

3.  Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation.

Authors:  Chandra Durgampudi; Pawan Noel; Krutika Patel; Rachel Cline; Ram N Trivedi; James P DeLany; Dhiraj Yadav; Georgios I Papachristou; Kenneth Lee; Chathur Acharya; Deepthi Jaligama; Sarah Navina; Faris Murad; Vijay P Singh
Journal:  Am J Pathol       Date:  2014-06       Impact factor: 4.307

4.  Carbon monoxide-based therapy ameliorates acute pancreatitis via TLR4 inhibition.

Authors:  Jing Xue; Aida Habtezion
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

5.  Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.

Authors:  Irene Ramos-Álvarez; Lingaku Lee; Robert T Jensen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

6.  Zymogen activation in a reconstituted pancreatic acinar cell system.

Authors:  Edwin C Thrower; Alexander P E Diaz de Villalvilla; Thomas R Kolodecik; Fred S Gorelick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-08       Impact factor: 4.052

7.  Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis.

Authors:  Enrico Lupia; Alberto Goffi; Paolo De Giuli; Ornella Azzolino; Ornella Bosco; Enrico Patrucco; Maria Cristina Vivaldo; Marco Ricca; Matthias P Wymann; Emilio Hirsch; Giuseppe Montrucchio; Giorgio Emanuelli
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 8.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

9.  Interleukin-32 expression in the pancreas.

Authors:  Atsushi Nishida; Akira Andoh; Osamu Inatomi; Yoshihide Fujiyama
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

Review 10.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.